These targeted accumulation patterns align with the body's natural glutathione distribution, suggesting that the acetyl modification preserves the molecule's inherent tissue selectivity
Significantly downregulated proteins when adjusting for body weight effects in STEP 1 known to be associated with CVD risk included tenascin C (TNC), NT-proBNP, thrombospondin 2 (THBS2), complement component C1q receptor (cluster of differentiation 93 (CD93)), macrophage scavenger receptor 1extracellular domain (MSR1) and angiopoietin-2 (ANGPT2)
The combined effect is a gradual, sustained lowering of blood sugar levels
People with certain health conditions, such as cystic fibrosis, diabetes, cancer, and hepatitis, also tend to have lower glutathione levels
Anxiety can heighten concerns about diabetes control, causing hypervigilance or even avoidance of essential tasks, which in turn disrupts glycemic management